Alnajashi, H. Rituximab As an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review. J. Contemp. Med. Sci. 2025, 11.